Before using this in research
The goal is not to adopt another tool. The goal is to reduce verified research time without weakening the evidence trail.
Best for
Biomedical, medical, and academic researchers working with single-cell RNA-seq data who need to infer and interpret ligand–receptor-mediated communication between annotated cell populations.
First step
Start with a quality-controlled single-cell expression matrix and reliable cell-type or cell-state annotations. Confirm that the biological question is suitable for transcriptome-based ligand–receptor inference before running CellChat.
A safer workflow
- 1Prepare input data, including normalized gene expression and metadata with cell identities, and ensure that rare or low-quality cell groups are handled appropriately.
- 2Run CellChat to identify overexpressed ligands, receptors, and ligand–receptor pairs, then infer potential communication probabilities between cell groups.
- 3Summarize communication at the pathway and network levels using CellChat visualizations such as interaction networks, pathway plots, and cell-group comparisons.
- 4Interpret results in biological context, compare conditions when relevant, and prioritize candidate interactions for validation with orthogonal experimental or clinical evidence.
Watch-outs
- CellChat infers potential communication from mRNA expression; it does not prove physical interaction, protein abundance, secretion, receptor activation, or functional causality.
- Results depend strongly on cell annotation quality, normalization choices, sample composition, database coverage, and the handling of batch effects or condition imbalance.
- Avoid overinterpreting dense network plots; focus on reproducible, biologically plausible interactions supported by pathway context and external evidence.
Evidence checks
- Check whether key ligands and receptors are expressed in the expected cell populations and are not driven by a small number of cells or low-quality clusters.
- Compare findings with known biology, independent datasets, spatial information, protein-level assays, perturbation studies, or clinical associations when available.
- When comparing groups, verify that observed differences are not explained by changes in cell abundance, sequencing depth, batch structure, or annotation inconsistencies.
Need the complete current version?
Open the full detail page
This English version is a curated decision page. The full current detail page remains available while the English library is being expanded.
Open current full detail